Literature DB >> 28069388

Vitamin D receptor deficit induces activation of renin angiotensin system via SIRT1 modulation in podocytes.

Nirupama Chandel1, Kamesh Ayasolla1, Hongxiu Wen1, Xiqian Lan1, Shabirul Haque1, Moin A Saleem2, Ashwani Malhotra1, Pravin C Singhal3.   

Abstract

Vitamin D receptor (VDR) deficient status has been shown to be associated with the activation of renin angiotensin system (RAS). We hypothesized that lack of VDR would enhance p53 expression in podocytes through down regulation of SIRT1; the former would enhance the transcription of angiotensinogen (Agt) and angiotensinogen II type 1 receptor (AT1R) leading to the activation of RAS. Renal tissues of VDR mutant (M) mice displayed increased expression of p53, Agt, renin, and AT1R. In vitro studies, VDR knockout podocytes not only displayed up regulation p53 but also displayed enhanced expression of Agt, renin and AT1R. VDR deficient podocytes also displayed an increase in mRNA expression for p53, Agt, renin, and AT1R. Interestingly, renal tissues of VDR-M as well as VDR heterozygous (h) mice displayed attenuated expression of deacetylase SIRT1. Renal tissues of VDR-M mice showed acetylation of p53 at lysine (K) 382 residues inferring that enhanced p53 expression in renal tissues could be the result of ongoing acetylation, a consequence of SIRT1 deficient state. Notably, podocytes lacking SIRT1 not only showed acetylation of p53 at lysine (K) 382 residues but also displayed enhanced p53 expression. Either silencing of SIRT1/VDR or treatment with high glucose enhanced podocyte PPAR-y expression, whereas, immunoprecipitation (IP) of their lysates with anti-retinoid X receptor (RXR) antibody revealed presence of PPAR-y. It appears that either the deficit of SIRT1 has de-repressed expression of PPAR-y or enhanced podocyte expression of PPAR-y (in the absence of VDR) has contributed to the down regulation of SIRT1.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28069388      PMCID: PMC5331620          DOI: 10.1016/j.yexmp.2017.01.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  33 in total

1.  Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.

Authors:  Beum-Soo An; Luz E Tavera-Mendoza; Vassil Dimitrov; Xiaofeng Wang; Mario R Calderon; Hui-Jun Wang; John H White
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

2.  Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors.

Authors:  Partab Rai; Tejinder Singh; Rivka Lederman; Amrita Chawla; Dileep Kumar; Kang Cheng; Gautam Valecha; Peter W Mathieson; Moin A Saleem; Ashwani Malhotra; Pravin C Singhal
Journal:  Cell Signal       Date:  2014-12-24       Impact factor: 4.315

3.  The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.

Authors:  María Jesús Larriba; Félix Bonilla; Alberto Muñoz
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-06       Impact factor: 4.292

Review 4.  Childhood tuberculosis and malnutrition.

Authors:  Devan Jaganath; Ezekiel Mupere
Journal:  J Infect Dis       Date:  2012-10-02       Impact factor: 5.226

Review 5.  Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals.

Authors:  Allison Ross Eckard; Grace A McComsey
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

6.  Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.

Authors:  Fatouma Alimirah; Xinjian Peng; Liang Yuan; Rajeshwari R Mehta; Andreas von Knethen; Divaker Choubey; Rajendra G Mehta
Journal:  Exp Cell Res       Date:  2012-08-04       Impact factor: 3.905

Review 7.  How does SIRT1 affect metabolism, senescence and cancer?

Authors:  Christopher L Brooks; Wei Gu
Journal:  Nat Rev Cancer       Date:  2008-12-29       Impact factor: 60.716

8.  Epigenetic Modulation of Human Podocyte Vitamin D Receptor in HIV Milieu.

Authors:  Nirupama Chandel; Kameshwar S Ayasolla; Xiqian Lan; Maria Sultana-Syed; Amrita Chawla; Rivka Lederman; Vasupradha Vethantham; Moin A Saleem; Praveen N Chander; Ashwani Malhotra; Pravin C Singhal
Journal:  J Mol Biol       Date:  2015-07-22       Impact factor: 5.469

9.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

10.  Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney.

Authors:  Himanshu Vashistha; Pravin C Singhal; Ashwani Malhotra; Mohammad Husain; Peter Mathieson; Moin A Saleem; Cyril Kuriakose; Surya Seshan; Anna Wilk; Luis Delvalle; Francesca Peruzzi; Marco Giorgio; Pier Giuseppe Pelicci; Oliver Smithies; Hyung-Suk Kim; Masao Kakoki; Krzysztof Reiss; Leonard G Meggs
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-26
View more
  14 in total

Review 1.  Sirtuins in Renal Health and Disease.

Authors:  Marina Morigi; Luca Perico; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2018-04-30       Impact factor: 10.121

2.  Keloid-associated lymphoid tissues in keloid lesions express vitamin D receptor.

Authors:  Ethan J Kilmister; Kim H Lim; Tinte Itinteang; Bede van Schaijik; Helen D Brasch; Paul F Davis; Swee T Tan
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  Charting the transcriptional landscape of cells of renin lineage following podocyte depletion.

Authors:  Aaron D McClelland; Julia Lichtnekert; Diana G Eng; Jeffrey W Pippin; Kenneth W Gross; Sina A Gharib; Stuart J Shankland
Journal:  PLoS One       Date:  2017-12-12       Impact factor: 3.240

Review 4.  Vitamin D and Cardiovascular Risk: which Implications in Children?

Authors:  Silvia Savastio; Erica Pozzi; Francesco Tagliaferri; Roberta Degrandi; Roberta Cinquatti; Ivana Rabbone; Gianni Bona
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

Review 5.  Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases.

Authors:  Shikun Yang; Aimei Li; JianWen Wang; Jun Liu; Yachun Han; Wei Zhang; Yan Chun Li; Hao Zhang
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

6.  Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy.

Authors:  Qi Yu; Yingjin Qiao; Dongwei Liu; Fengxun Liu; Congcong Gao; Jiayu Duan; Lulu Liang; Xueqi Di; Yi Yuan; Yukui Gao; Siwan Cui; Yilu Qin; Tianfang Li; Zhaohui Zheng; Zhangsuo Liu
Journal:  Arthritis Res Ther       Date:  2019-01-11       Impact factor: 5.156

Review 7.  Role of Vitamin D Status in Diabetic Patients with Renal Disease.

Authors:  Guido Gembillo; Valeria Cernaro; Antonino Salvo; Rossella Siligato; Alfredo Laudani; Michele Buemi; Domenico Santoro
Journal:  Medicina (Kaunas)       Date:  2019-06-13       Impact factor: 2.430

8.  Potential Genes Associated with COVID-19 and Comorbidity.

Authors:  Shanshan Feng; Fuqiang Song; Wenqiong Guo; Jishan Tan; Xianqin Zhang; Fengling Qiao; Jinlin Guo; Lin Zhang; Xu Jia
Journal:  Int J Med Sci       Date:  2022-01-24       Impact factor: 3.738

9.  Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.

Authors:  Farhan Cyprian; Eleftheria Lefkou; Katerina Varoudi; Guillermina Girardi
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

10.  Association of vitamin D receptor TaqI and ApaI genetic polymorphisms with nephrolithiasis and end stage renal disease: a meta-analysis.

Authors:  Tajamul Hussain; Shaik M Naushad; Anwar Ahmed; Salman Alamery; Arif A Mohammed; Mohamed O Abdelkader; Nasser Abobakr Nasser Alkhrm
Journal:  BMC Med Genet       Date:  2019-12-10       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.